Irlande


  • 29-July-2016

    English

    Health Policy in Your Country

    This new OECD series aims to highlight the latest data in selected countries, to explain their health care systems and to provide key information in a clear and concise way. Each country snapshot highlights the most pertinent issues, be it smoking, obesity, surgical interventions, consumption of antibiotics, physicians density, etc., with the help of key statistics and are followed by brief policy recommendations.

    Related Documents
  • 15-March-2016

    English, PDF, 382kb

    Fact sheet: Trends in Medical Education and Training in Ireland

    Entry to medical education in Ireland can occur in two ways: students can access it directly from secondary school (in which case it takes them 5 to 6 years to complete the programme) or after receiving a first bachelor degree (in which case the programme can be completed in 4 years).

    Related Documents
  • 23-February-2016

    English, PDF, 263kb

    Overview of Health Policy in Ireland

    Although Ireland has seen remarkable improvements in the health of its population in the last decades, several challenges lie ahead for its health system. Based on available OECD analyses, further progress could be made to promote efficient use of hospital resources, strengthen primary care, address high pharmaceutical spending and prevent the spread of risk factors including obesity and alcohol consumption.

    Related Documents
  • 3-December-2014

    English, PDF, 271kb

    Health at a Glance: Europe 2014 - Briefing Note for Ireland

    Despite cuts in recent years, health spending as a share of GDP in Ireland remains slightly higher than the EU average and pharmaceutical spending in particular remains relatively high.

    Related Documents
  • 20-November-2013

    English, PDF, 467kb

    Prevention and value for money in health spending must remain a priority for Ireland, says OECD Health at a Glance report

    Ireland continues to make substantive headway in improving health outcomes, but more can be done in reducing risk-factors for major diseases and improving value-for-money in health spending, according to a new OECD report.

    Related Documents
  • 21-février-2012

    Français

    Mardi Gras : un bon jour pour parler d’obésité ?

    De plus en plus de gens sont en surpoids ou obèses dans les pays développés, les condamnant à des années de mauvaise santé et à une mort prématurée. Cependant, de nouvelles données de l'OCDE montrent que le taux d'obésité ralenti dans certains pays.

    Documents connexes
    Also AvailableEgalement disponible(s)
  • 7-February-2011

    English

    OECD Health Working Paper No. 55: Mortality Amenable to Health Care in 31 OECD Countries: Estimates and Methodological Issues

    The mortality amenable to health care is defined as a possible indicator to measure the health care systems performance in preventing premature deaths that can be avoided by appropriate health care intervention. This paper assesses the feasibility of using this indicator in OECD countries.

    Related Documents
  • 20-avril-2009

    Français

    Maladie, invalidité et travail : surmonter les obstacles (Vol. 3) - Danemark, Finlande, Irlande et Pays-Bas

    Trop de travailleurs quittent pour toujours le marché du travail pour raison de santé. Et trop de personnes affectées d’un handicap se voient refuser la possibilité de travailler. Ce troisième rapport dans la série Maladie, invalidité et travail analyse les facteurs qui pourraient expliquer ce paradoxe. Il examine particulièrement des cas au Danemark, en Finlande, Irlande et au Pays-Bas et met en lumière le rôle des institutions et des politiques. L'ouvrage recommande un éventail de réformes susceptibles de répondre aux défis auxquels ces quatre pays font face.
  • 31-October-2006

    English

    Creation and Governance of Human Genetic Research Databases

    Summarises proceedings of a conference looking at examples of human genetic research databases, how they are established, how they are managed and governed, how they might be commercialised, and what the policy considerations might be.